A tetravalent bispecific protein enables targeted degradation of VCAM-1 and VEGFR for treatment of choroidal neovascularization.
- DOI
- 10.1073/pnas.2613631123
- Published
- 2026 Nov 10
- Container
- Proceedings of the National Academy of Sciences of the United States of America
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1073/pnas.2613631123,
title = {A tetravalent bispecific protein enables targeted degradation of VCAM-1 and VEGFR for treatment of choroidal neovascularization.},
author = {Zhang J and Du M and Ge L and Cao Y and Jiang J and Yin X and Chen G and Wang Q},
year = {2026},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
doi = {10.1073/pnas.2613631123},
url = {https://doi.org/10.1073/pnas.2613631123}
}RIS
TY - JOUR TI - A tetravalent bispecific protein enables targeted degradation of VCAM-1 and VEGFR for treatment of choroidal neovascularization. AU - Zhang J AU - Du M AU - Ge L AU - Cao Y AU - Jiang J AU - Yin X AU - Chen G AU - Wang Q PY - 2026 JO - Proceedings of the National Academy of Sciences of the United States of America DO - 10.1073/pnas.2613631123 UR - https://doi.org/10.1073/pnas.2613631123 ER -
APA
J, Z., M, D., L, G., Y, C., J, J., X, Y., G, C., & Q, W. (2026). A tetravalent bispecific protein enables targeted degradation of VCAM-1 and VEGFR for treatment of choroidal neovascularization.. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2613631123
Source records
- pubmed · retrieved 2026-11-10T10:03:41.277Z